Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, discusses different options for AL amyloidosis treatments, depending on eligibility for STEM cell transplant, and the subsequent success of these treatments. Interview recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.